Stay updated on ACTIV-2 Outpatient COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTIV-2 Outpatient COVID-19 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page displays the ACTIV-2 outpatient COVID-19 study record, including its treatments, eligibility criteria, outcomes, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-07T14:18:39.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:50:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, noting that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T18:10:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2. The study record still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T18:07:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-10T19:00:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link.
    Difference
    0.5%
    Check dated 2026-10-03T18:22:08.000Z thumbnail image

Stay in the know with updates to ACTIV-2 Outpatient COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.